Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study

Condition:   Pathological Response Rate, Circulating Tumour DNA Intervention:   Diagnostic Test: MeD-seq Sponsor:   Erasmus Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials